ACT-209905

CAT: 0804-HY-12616Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-12616Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
ACT-209905 is a S1P1 receptor agonist. ACT-209905 can inhibit glioblastoma (GBM) cell growth and migration. ACT-209905 also has immunomodulating activity, and can be used in research of autoimmune diseases[1].
CAS Number
[1062670-13-6]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
LPL Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/act-209905.html
Solubility
10 mM in DMSO
Smiles
O=C(NC[C@H](O)COC1=C(C)C=C(C2=NOC(C3=CC(N(CC)CC)=NC(C)=C3)=N2)C=C1CC)CO
Molecular Formula
C26H35N5O5
Molecular Weight
497.59
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Bien-Möller S, et al. The Putative S1PR1 Modulator ACT-209905 Impairs Growth and Migration of Glioblastoma Cells In Vitro. Cancers (Basel) . 2023 Aug 26;15 (17) :4273.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-124071-01ACT-389949
HY-101834-01ACT-462206
HY-153240ACT-672125
HY-108683ACT-335827
HY-149055-01ACT-777991
HY-111817-01ACT-451840
HY-U00262ACT 178882
HY-118036ACT-387042
HY-135500-01ACT-373898
HY-119085ACT-281959

Alternative Products

CatalogName
MBS5776286ACT-209905
YP-W16964-01Human ACT (ACT) ELISA Kit
MBS132402-01Macitentan (ACT 064992; ACT-064992)
MBS3613109-01ACT-389949
M12099-01ACT-541468
MBS3840044-01ACT-335827
4983/10ACT 335827
MBS5765572ACT-678689
571533ACT-451840
YF-PA16322anti-ACT

Popular Products